Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Renosen Pharmaceuticals Private Limited, Promoter Group. Insider active across 1 company, notably Remus Pharmaceuticals Limited. Cumulatively, 73 filings have been published. History available since 4 September 2023. The latest transaction was disclosed on 19 December 2025 (Purchase). Regulator: SEBI (PIT + SAST). The full history is accessible without signup.
Companies and markets linked to Renosen Pharmaceuticals Private Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
100 shares@ ₹7,179.750.9% of flowEquity SharesSEBI:099f80710b26bf636f4448543015e6d64f00711f
25 of 73 declarations
About Renosen Pharmaceuticals Private Limited
Renosen Pharmaceuticals Private Limited is a Promoter Group of Remus Pharmaceuticals Limited (XBOM). The entity has 73 filings in total, and across the recent sampled filings observed from 2023-09-06 to 2025-12-23, the transactions show purchases of EUR 934796 and no sales, with the modal transaction nature listed as Purchase.